PeopleBio, Inc. (KOSDAQ: 304840)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,160.00
-90.00 (-2.77%)
Dec 19, 2024, 2:34 PM KST
10.30%
Market Cap 64.46B
Revenue (ttm) 4.37B
Net Income (ttm) -12.31B
Shares Out 21.03M
EPS (ttm) -574.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 110,107
Open 3,170.00
Previous Close 3,250.00
Day's Range 3,150.00 - 3,230.00
52-Week Range 2,590.00 - 6,090.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 18, 2025

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2002
Employees 66
Stock Exchange KOSDAQ
Ticker Symbol 304840
Full Company Profile

Financial Performance

In 2023, PeopleBio's revenue was 4.45 billion, an increase of 0.18% compared to the previous year's 4.44 billion. Losses were -16.03 billion, 12.1% more than in 2022.

Financial Statements

News

There is no news available yet.